Concepta surges on news of UK myLotus launch

Women attending the show will be able to exclusively buy a Starter Pack at a 'Special Launch' price of £199

myLotus tester
myLotus received CE-Mark certification earlier this week

Concepta PLC (LON:CPT) shares surged in lunchtime trading Wednesday after it said it will launch its myLotus product in the UK at the Fertility Show in London, to be held on the 3rd and 4th of November.

The healthcare group said its stand at the show, to be held in Olympia, will also include representation from key opinion leaders, fertility doctors and health experts who will answer questions on myLotus products.

READ: Concepta jumps as myLotus products receive CE-Mark certification

Earlier this week, Concepta said that its myLotus product range, which helps women monitor their fertility levels, had received CE-Mark certification from regulators, allowing its sale in the UK.

Matthew Walls, chairman of Concepta, said women attending the show would be able to exclusively buy a Starter Pack, consisting of a myLotus monitor, 3 packs of 20 ovulation tests and 3 packs of 3 pregnancy tests, at the 'Special Launch' price of £199.

He added that the products would also be made available online.

Shares were up 8.1% at 4p.

-- Adds share price --

Quick facts: Concepta

Price: £0.02

Market: LSE
Market Cap: £6.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Concepta named herein, including the promotion by the Company of Concepta in any Content on the Site, the Company receives from said issuer...



Investor Update: Concepta looks ahead to first births with double digit...

Top stories from the Proactive Investors UK newsroom. Fertility aid group Concepta (LON:CPT) says more than ten women using its mylotus treatment have now become pregnant with the first babies expected later this year. The company says user testimonials for the mylotus monitor and app...

on 9/7/19

2 min read